Long-Term Follow up of BMT CTN 0901, a Randomized Phase III Trial Comparing Myeloablative (MAC) to Reduced Intensity Conditioning (RIC) Prior to Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) (MAvRIC Trial)
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.075
Abstract: BMT CTN 0901 enrolled patients with MDS (N=54) or AML (N=218) (median age of 55 years) who had Overall survival (OS) at 4 years was 65% and 49% for MAC and RIC (p=0.02), respectively. In… read more here.
Keywords: trial; bmt ctn; ctn 0901; long term ... See more keywords